SITC 2018 Abstracts

Clinical Trials (In Progress)

Return to Category List

Search word or phrase:   New Search

P331A phase 1a clinical trial of NLG802, a prodrug of indoximod with enhanced pharmacokinetic propertiesOlivier Rixe, MD, PhD; Thomas George, MD; Heloisa Soares; Agnieszka Marcinowicz; Nicholas Vahanian, MD; Charles Link, Jr., MD; Edouard Dupis; Eugene P. Kennedy, MD, FACS; Mario Mautino, PhD Clinical study; Clinical trial; Immune suppression; Solid tumors